Company Filing History:
Years Active: 1987-1992
Title: Innovations in Vaccination: The Contributions of Geoffrey C Schild
Introduction
Geoffrey C Schild is a prominent inventor based in London, GB. He has made significant contributions to the field of vaccination, particularly in the development of influenza vaccines and enterovirus diagnostics. With a total of 4 patents to his name, Schild's work has had a substantial impact on public health.
Latest Patents
One of his latest patents focuses on an influenza vaccine. This innovation involves selecting a strain of influenza virus, specifically human influenza types A or B, for vaccine formulation. The process includes isolating candidate influenza viruses in embryonated hens' eggs and determining their antigenic similarities to strains grown exclusively in animal cells. This method allows for the selection of at least one 'cell-like' strain or a reassortant with its HA and NA genes for the vaccine.
Another notable patent pertains to peptides useful in vaccination against enteroviruses. This synthetic peptide is designed for use in vaccination against diseases caused by enteroviruses, particularly poliovirus. The peptide is coded for by specific codons in the RNA sequence of the structural capsid protein VP1 of the poliovirus type 3 Sabin strain, or by equivalent codons of another enterovirus.
Career Highlights
Geoffrey C Schild is associated with the National Research Development Corporation, where he continues to advance his research and innovations in the field of vaccines. His work has been instrumental in developing effective vaccination strategies that address critical health challenges.
Collaborations
Schild has collaborated with notable colleagues, including David M Evans and Jeffrey W Almond. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in vaccination.
Conclusion
Geoffrey C Schild's contributions to vaccine development are noteworthy and reflect his commitment to improving public health. His innovative patents and collaborations underscore the importance of research in combating infectious diseases.